Stock listing

MEDCL Stock Price, News, Filings & Events — Medincell Sa

Selected listing: MEDCL · EURONEXT · EUR · FR

This page tracks Medincell Sa's MEDCL:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MEDCL:EURONEXT. MEDCL:EURONEXT is the stock-level entry point for investors researching Medincell Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Medincell SA is a public company listed on the French market under the ticker MEDCL. The company has a market capitalization of approximately €1.05 billion. Medincell focuses on developing innovative drug delivery solutions to improve patient outcomes.

MEDCL:EURONEXTEURFRUpdated September 12, 2026
Medincell Sa logo
Ticker
MEDCL:EURONEXT
Asset type
Stock
Market cap
$909.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR

Medincell Sa MEDCL:EURONEXT stock context

This page tracks Medincell Sa's MEDCL:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MEDCL:EURONEXT. MEDCL:EURONEXT is the stock-level entry point for investors researching Medincell Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Medincell SA is a public company listed on the French market under the ticker MEDCL. The company has a market capitalization of approximately €1.05 billion. Medincell focuses on developing innovative drug delivery solutions to improve patient outcomes.

Latest news from Medincell Sa

All Medincell Sa news →

Medincell Sa earnings calls

Research Medincell Sa

Alternate listings